Tranilast inhibits transplant-associated coronary arteriosclerosis in a murine model of cardiac transplantation

European Journal of Pharmacology

Volumn 433, Issue 2-3, 2001, Pages 163-168

  Saiura, Akio ^a   Sata, Masataka ^a   Hirata, Yasunobu ^a   Nagai, Ryozo ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Arteriosclerosis; Proliferation; Smooth muscle cell; Tranilast; Transplantation

Indexed keywords

ANTIMITOTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P21; TRANILAST; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFECT; DRUG EFFICACY; HEART TRANSPLANTATION; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; REGULATORY MECHANISM; RESTENOSIS; SURVIVAL TIME;

ANIMALS; ANTHRANILIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DIVISION; CORONARY ARTERIOSCLEROSIS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HEART TRANSPLANTATION; HYPERPLASIA; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MUSCLE, SMOOTH, VASCULAR; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035930840     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01501-1     Document Type: Article

References (31)

1. Cardiac allograft vasculopathy is abrogated by anti-CD8 monoclonal antibody therapy
2. Cardiac transplant atherosclerosis
3. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells
4. Rapamycin for immunosuppression in organ allografting
5. Modulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis
6. Microsatellite mutation of type II transforming growth factor-beta receptor is rare in atherosclerotic plaques
7. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection
8. Pathology of hepatic transplantation. A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid combination
9. Principles for human gene therapy studies
10. Cyclosporine induces cancer progression by a cell-autonomous mechanism
11. The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: A double-blind, placebo-controlled trial
12. Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis
13. Efficacy of tranilast on restenosis after coronary stenting
14. Gene therapy for attenuating cardiac allograft arteriopathy using ex vivo E2F decoy transfection by HVJ-AVE-liposome method in mice and nonhuman primates
15. Effectiveness of tranilast on restenosis after directional coronary atherectomy
16. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
17. Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease
18. Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats
19. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins
20. Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia
21. Genetically modified mice as models of transplant atherosclerosis
22. Coronary atherosclerosis in transplanted mouse hearts
23. Circulating smooth muscle progenitor cells contribute to atherosclerosis
24. Fas ligand overexpression on allograft endothelium inhibits inflammatory cell infiltration and transplant-associated intimal hyperplasia
25. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy
26. Cyclosporine-associated renal arteriopathy resulting in loss of allograft function
27. Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide
28. waf1/cip1/sdi1 and p53
29. Impact of tranilast on restenosis after coronary angioplasty: Tranilast restenosis following angioplasty trial (TREAT)
30. Ischemia-induced transplant arteriosclerosis in the rat. Induction of peptide growth factor expression
31. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries